Showing 61-70 of 108 results for "".
- Dr. Sebastian Cotofana Shares Unpublished Research Targeting Glabellar Lines with Neurotoxins at SCALEhttps://modernaesthetics.com/news/dr-sebastian-cotofana-shares-unpublished-research-targeting-glabellar-lines-with-neurotoxins-at-scale/2475377/The 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE) was held from May 14 to 18 at the Grand Hyatt in Nashville, Tennessee. The agenda included an update on neurotoxin related to facial anatomy for improved aesthetic outcomes from Seb
- AestheticWires’s Toxin Pipeline Watch: RelabotulinumtoxinA Smoothes Crow’s Feet and Frown Lines Quickly and Results Last in Phase IIIb Studieshttps://modernaesthetics.com/news/aestheticwiress-toxin-pipeline-watch-relabotulinumtoxina-smoothes-crows-feet-and-frown-lines-quickly-and-results-last-in-phase-iiib-studies/2473537/RelabotulinumtoxinA produces rapid and long-lasting effects on crow’s feet and frown kines, according to topline results from two phase IIIb studies. Galderma’s relabotulinumtoxinA is a novel liquid formulation of botulinum toxin A currently being investigated globally.
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- Hallura’s New BiOLinkMatrix HA Aesthetic Dermal Fillers Perform Well in Lips, Cheeks, and Smile Lineshttps://modernaesthetics.com/news/halluras-new-biolinkmatrix-ha-aesthetic-dermal-fillers-performs-well-in-lips-cheeks-and-smile-lines/2473203/Hallura Ltd’s hyaluronic acid (HA) dermal fillers with its proprietary BiOLinkMatrix platform performed well for lip enhancement, nasolabial folds correction. and cheek enhancement, according to topline results. The pro
- WCD News: Deka Rolls Out Three New Laser and Microwave Platformshttps://modernaesthetics.com/news/wcd-news-deka-rolls-out-three-new-laser-and-microwave-platforms/2473441/DEKA is launching of its new PRO line at the 25th World Congress of Dermatology in Singapore. Based on laser and microwave technology, the line includes the Again PRO, RedTouch PRO, and Onda PRO platforms. The Again PRO platform, a combinatio
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- ASDS News: Patients Love Galderma's Investigational Liquid Botulinum Toxinhttps://modernaesthetics.com/news/asds-news-patients-love-galdermas-investigational-liquid-botulinum-toxin/2473312/Galderma's investigational ready-to-use liquid botulinum toxin RelabotulinumtoxinA scored high patient satisfaction and psychological well-being ratings for the treatment of glabellar lines and lateral canthal lines in addition to previously reported safety and efficacy, according to pre
- FDA Approves Daxxify from Revancehttps://modernaesthetics.com/news/fda-approves-daxxify-from-revance/2473295/Daxxify™ (DaxibotulinumtoxinA-lanm) from Revance is FDA approved for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is the first and only neuromodulator stabilized with Peptide Exchange Technology™ (PXT) and is free of both human serum
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr
- Revance Shares Positive Efficacy and Duration Data for RT002https://modernaesthetics.com/news/revance-share-positive-efficacy-and-duration-data-for-rt002/2471986/Revance Therapeutics, Inc.'s long-acting neuromodulator daxibotulinumtoxinA for Injection (RT002) with its proprietary stabilizing excipient peptide technology delivered positive top-line results in alleviating moderate to severe glabellar lines in the SAKURA 3 Phase 3 open-label, long-term s